59 related articles for article (PubMed ID: 3088258)
1. Doxorubicin and doxorubicinol-induced alterations in human polymorphonuclear leukocyte oxygen metabolite generation.
Nielson CP; Brenner D; Olson RD
J Pharmacol Exp Ther; 1986 Jul; 238(1):19-25. PubMed ID: 3088258
[TBL] [Abstract][Full Text] [Related]
2. Polymorphonuclear leucocyte membrane-stimulated oxidative metabolic activity---the effect of divalent cations and cytochalasins.
Williams AJ; Cole PJ
Immunology; 1981 Dec; 44(4):847-58. PubMed ID: 6274795
[TBL] [Abstract][Full Text] [Related]
3. Beta-adrenoceptor-mediated modulation of calcium ionophore activated polymorphonuclear leucocytes.
Mack JA; Nielson CP; Stevens DL; Vestal RE
Br J Pharmacol; 1986 Jun; 88(2):417-23. PubMed ID: 2873859
[TBL] [Abstract][Full Text] [Related]
4. Luminol dependent chemiluminescence and thiol group oxidation provoked by neutrophils is attributable to different oxidizing species.
Jenner DE; Holt ME; Campbell AK
J Biolumin Chemilumin; 1987 May; 1(3):165-71. PubMed ID: 3503525
[TBL] [Abstract][Full Text] [Related]
5. Modulation of polymorphonuclear leukocyte function by doxorubicin (Adriamycin) and alpha tocopherol (vitamin E).
Pickering LK; Cleary TG; Kletzel M; Wang YM; Parra MM
J Clin Lab Immunol; 1983 Jun; 11(2):95-100. PubMed ID: 6876145
[TBL] [Abstract][Full Text] [Related]
6. A population pharmacokinetic model for doxorubicin and doxorubicinol in the presence of a novel MDR modulator, zosuquidar trihydrochloride (LY335979).
Callies S; de Alwis DP; Wright JG; Sandler A; Burgess M; Aarons L
Cancer Chemother Pharmacol; 2003 Feb; 51(2):107-18. PubMed ID: 12647011
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of stobadine on FMLP-induced chemiluminescence in human whole blood and isolated polymorphonuclear leukocytes.
Drábiková K; Jancinová V; Nosál R; Pecivová J; Macicková T; Turcáni P
Luminescence; 2007; 22(2):67-71. PubMed ID: 16871535
[TBL] [Abstract][Full Text] [Related]
8. Effect of iron (III) in the presence of various ligands on the phagocytic and metabolic activity of human polymorphonuclear leukocytes.
van Asbeck BS; Marx JJ; Struyvenberg A; van Kats JH; Verhoef J
J Immunol; 1984 Feb; 132(2):851-6. PubMed ID: 6690620
[TBL] [Abstract][Full Text] [Related]
9. Alteration in doxorubicin and doxorubicinol plasma concentrations with repeated courses to patients.
Morris RG; Reece PA; Dale BM; Green RM; Kotasek D; Saccoia NC; Sage RE
Ther Drug Monit; 1989; 11(4):380-3. PubMed ID: 2741185
[TBL] [Abstract][Full Text] [Related]
10. Toxicokinetics of the active doxorubicin metabolite, doxorubicinol, in sulphur-crested cockatoos (Cacatua galerita).
Gilbert CM; Filippich LJ; McGeary RP; Charles BG
Res Vet Sci; 2007 Aug; 83(1):123-9. PubMed ID: 17197005
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the therapeutic efficiency of Voltarene by using the in vitro chemiluminescence emitted by leukocytes polymorphonuclear.
Olinescu R; Radu D; Pintea G; Militaru M
Rom J Intern Med; 1991; 29(3-4):199-204. PubMed ID: 1784949
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel and docetaxel stimulation of doxorubicinol formation in the human heart: implications for cardiotoxicity of doxorubicin-taxane chemotherapies.
Salvatorelli E; Menna P; Cascegna S; Liberi G; Calafiore AM; Gianni L; Minotti G
J Pharmacol Exp Ther; 2006 Jul; 318(1):424-33. PubMed ID: 16614166
[TBL] [Abstract][Full Text] [Related]
13. Effect of serine proteinase inhibitors on intracellular free calcium rise in human polymorphonuclear leukocytes after stimulation with receptor agonists.
Nowak D; Król M; Białasiewicz P
Arch Immunol Ther Exp (Warsz); 1998; 46(2):121-6. PubMed ID: 9613710
[TBL] [Abstract][Full Text] [Related]
14. Oxygenation activities of chicken polymorphonuclear leukocytes investigated by selective chemiluminigenic probes.
Merrill GA; Bretthauer R; Wright-Hicks J; Allen RC
Lab Anim Sci; 1996 Oct; 46(5):530-8. PubMed ID: 8905586
[TBL] [Abstract][Full Text] [Related]
15. Effect of synthetic metalloproteinase inhibitor or citrate on neutrophil chemotaxis and the respiratory burst.
Pfister RR; Haddox JL; Sommers CI
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1340-9. PubMed ID: 9191597
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of doxorubicin and its metabolites in human autopsy heart and other tissues.
Stewart DJ; Grewaal D; Green RM; Mikhael N; Goel R; Montpetit VA; Redmond MD
Anticancer Res; 1993; 13(6A):1945-52. PubMed ID: 8297100
[TBL] [Abstract][Full Text] [Related]
17. Toxicity of doxorubicin metabolites to human marrow erythroid and myeloid progenitors in vitro.
Dessypris EN; Brenner DE; Hande KR
Cancer Treat Rep; 1986 Apr; 70(4):487-90. PubMed ID: 3698042
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-derived metabolites induce release of cytochrome C and inhibition of respiration on cardiac isolated mitochondria.
Clementi ME; Giardina B; Di Stasio E; Mordente A; Misiti F
Anticancer Res; 2003; 23(3B):2445-50. PubMed ID: 12894526
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of histamine-induced leukocyte rolling in the undisturbed microcirculation of the rat mesentery.
Yamaki K; Thorlacius H; Xie X; Lindbom L; Hedqvist P; Raud J
Br J Pharmacol; 1998 Feb; 123(3):390-9. PubMed ID: 9504378
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant rat tumor necrosis factor-alpha and interferon-gamma on the respiratory burst of rat polymorphonuclear leukocytes in whole blood.
Vondrácek J
Folia Biol (Praha); 1997; 43(3):115-21. PubMed ID: 9338118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
